While current engineered T-cell therapies have shown great promise in treatment of cancers in the clinic, they are limited by serious side-effects and suppressive tumor environments. My research is to design synthetic regulatory circuits to provide engineered T-cells with the ability to respond dynamically to their environment and thereby operate at an optimal level of activity.